[Studies on the present state of resistance to framycetin among strains of staphylococci, enterobacteriaceae and pseudomonas].
D003352:Corynebacterium / Q000187:drug effects; D004305:Dose-Response Relationship, Drug; D004352:Drug Resistance, Microbial; D004755:Enterobacteriaceae / Q000187:drug effects*; D004926:Escherichia coli / Q000187:drug effects; D005601:Framycetin / Q000008:administration & dosage / Q000494:pharmacology*; D006801:Humans; D007709:Klebsiella / Q000187:drug effects; D008826:Microbial Sensitivity Tests; D011511:Proteus / Q000187:drug effects; D011513:Proteus mirabilis / Q000187:drug effects; D011514:Proteus vulgaris / Q000187:drug effects; D011549:Pseudomonas / Q000187:drug effects*; D011550:Pseudomonas aeruginosa / Q000187:drug effects; D012477:Salmonella enteritidis / Q000187:drug effects; D012486:Salmonella typhimurium / Q000187:drug effects; D012705:Serratia / Q000187:drug effects; D012763:Shigella flexneri / Q000187:drug effects; D013210:Staphylococcus / Q000187:drug effects*; D013302:Streptomyces / Q000187:drug effects
D005601:Framycetin